Markets
Cantor
@cantor_f...
Bought SRPT
Shares
down -11.65%
At 118.3, Exited 104.5
Given the recent FDA approval expansion for Sarepta's Elevidys and the projected revenue growth in the gene therapy market, I believe that SRPT is poi...
Read
More
Thesis
Given the recent FDA approval expansion for Sarepta's Elevidys and the projected revenue growth in the gene therapy market, I believe that SRPT is poised for significant price appreciation as its market potential continues to expand, making it a strong long-term investment opportunity.
Go back
Soros
@soros-fu...
Bought SRPT
Shares
down -5.52%
At 124.9, Now 118.0
Thesis
Go back
Pinebridge
@pinebrid...
Bought SRPT
Shares
down -5.52%
At 124.9, Now 118.0
Thesis
Go back
Hersh
@hersh
Bought SRPT
Calls
up 182%
At 1.0, Exited 2.81
Contract:
140 Strike Call for
Aug 23, 24
This idea is based on unusual options activity + it's important to note that this is a thinly traded name so consider playing shares instead of option...
Read
More
Thesis
This idea is based on unusual options activity + it's important to note that this is a thinly traded name so consider playing shares instead of options if you want to play. As long as 136.25 holds I like this one for a move into 142 ahead; BUT if it fails to hold support then this idea fails.
Go back
Point72
@point72-...
Bought SRPT
Shares
down -23.64%
At 156.8, Now 118.0
Trims & Adds
[] Currently down $1.8M
[-] 110d ago
Trimmed 12.1K shares @
124.89
[+] 202d ago
Initial 48.9K shares @
156.80
Thesis
Go back
Soros
@soros-fu...
Bought SRPT
Shares
up 17.22%
At 110.5, Exited 129.6
Thesis
Go back
